(S)-2-methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine-13CD3;(S)-Org 3770-13C-d3; Esmirtazapine-13C-d3; Org 44-20-13C-d3; S-(+)-Mirtazapine-13C-d3; (S)-1,2,3,4,10,14b-Hexahydro-2-methyl-pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine-13C-d3;(+)-Mirtazapine-13C-d3;(14bS)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine-13C-d3;(S)-6-Azamianserin-13C-d3;(S)-Mirtazapine-13C-d3
(S)-Mirtazapine-13C-d3 is a fully characterized chemical compound used as a reference standard of API Mirtazapine. The standard offered is compliant with regulatory guidelines. (S)-Mirtazapine-13C-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 61337-87-9 (non-d)
Related products
Mirtazapine-13C-d3 HCl
M.F.
M.W. 269.37 36.46
CAT# AR-M02040
CAS# 85650-52-8 (non-labelled and free base)
